TY  - JOUR
PY  - 2021//
TI  - [About the use of ketamine in emergency psychiatric settings]
JO  - Revue Medicale Suisse
A1  - Sergentanis, Ioannis
A1  - Vibert, Vincent
A1  - Costanza, Alessandra
A1  - de Néris, Mélanie
A1  - Besson, Marie
A1  - Kosel, Markus
A1  - Bondolfi, Guido
A1  - Ambrosetti, Julia
SP  - 303
EP  - 306
VL  - 17
IS  - 725
N2  - Ketamine and its S-enantiomer, esketamine, have shown to be promising molecules for use in psychiatry. Widely investigated for the treatment of drug-resistant depression, they could be used in emergency conditions, due to their rapid onset of action, in two main conditions : 1) psychomotor agitation, and 2) acute suicidal ideation and behavior (suicidal crisis). In particular, intranasal administration offers a non-invasive, safe and very easy to administer option. An effect begins a few hours to a day after intake and lasts for about a week. These molecules present an innovative option for the future and their specific use in psychiatric emergencies.<p /> <p>Language: fr</p>
LA  - fr
SN  - 1660-9379
UR  - http://dx.doi.org/
ID  - ref1
ER  -